cocktail
cocktail: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: Novo Nordisk A/S (NVO)
Development Pipeline (1)
| Company | Phase |
|---|---|
| Novo Nordisk A/S (NVO) | Phase 1 |
Clinical Trials (1)
An Open-label, Single-sequence, Crossover Study Investigating the Influence of UBT251 on Pharmacokinetics of Index Substrates for Cytochrome P450 Enzymes in Participants With Overweight or Obesity
Frequently asked questions
Who is developing cocktail?
cocktail is being developed by Novo Nordisk A/S.
How many clinical trials involve cocktail?
BioSniper tracks 1 clinical trial involving cocktail.
Analyze Novo Nordisk A/S & cocktail with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company